NCT07125924View on ClinicalTrials.gov

Intravesical Hyaluronic Acid (HA) for Preventing Radiation Cystitis on Bladder Cancer

NANot yet recruitingINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

August 22, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Bladder CancerRadiation Cystitis
Interventions
DEVICE

Blad-Care (sodium hyaluronate 1.6%, 800 mg/50 mL, BioPlus Co., Ltd.)

Bladder instillation of Blad-Care (sodium hyaluronate 1.6%, 800 mg/50 mL, BioPlus Co., Ltd.) will be administered aseptically once weekly for a total of five times following each session of radiotherapy.

OTHER

Normal Saline (NS)

Normal saline will be instilled into the bladder following the same schedule as the intervention group, i.e., five times after each radiotherapy session.

Trial Locations (1)

10408

National Cancer Center, Korea, Goyang-si

All Listed Sponsors
lead

National Cancer Center, Korea

OTHER_GOV